Articles by Richard Altus, ImpactRx - Pharmaceutical Executive


Articles by Richard Altus, ImpactRx

Avandia Sales Away

What did you do when you heard the safety news about Avandia? Here's what the rest of the market did, and why it matters to you.
Jul 30, 2007

Avandia's market share erosion was magnified further by the almost complete absence of new prescriptions being switched to Avandia from its competitors. In the weeks before the event, Avandia accounted for more than 20 percent of all switches by primary care physicians


Click here